SEC Form SC 13G/A filed by INmune Bio Inc. (Amendment)
SECURITIES AND EXCHANGE COMMISSION | ||
Washington, DC 20549 | ||
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
INmune Bio, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
45782T105
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ | Rule 13d-1(b) |
☐ | Rule 13d-1(c) |
☒ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 45782T105
1 |
| NAMES OF REPORTING PERSONS Xencor, Inc. | ||||
2 |
| CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) x
| ||||
3 |
| SEC USE ONLY
| ||||
4 |
| CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
| 5 |
| SOLE VOTING POWER
1,885,533 | ||
| 6 |
| SHARED VOTING POWER
0 | |||
| 7 |
| SOLE DISPOSITIVE POWER
1,885,533 | |||
| 8 |
| SHARED DISPOSITIVE POWER
0 | |||
9 |
| AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,885,533 | ||||
10 |
| CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐ | ||||
11 |
| PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.6%(1) | ||||
12 |
| TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO | ||||
(1) | This percentage is calculated based upon 17,843,303 shares of the Issuer’s Common Stock outstanding as set forth in the Issuer’s Form 10-Q for the third quarter ended September 30, 2021, filed with the Securities and Exchange Commission on November 3, 2021. |
Item 1(a). | Name of Issuer: |
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
Item 2(a). | Name of Person Filing: |
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
Item 2(c). | Citizenship: |
Item 2(d). | Title of Class of Securities: |
Item 2(e). | CUSIP Number: |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Item 4. | Ownership |
Item 5. | Ownership of 5 Percent or Less of a Class |
Item 6. | Ownership of More than 5 Percent on Behalf of Another Person: |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person: |
Item 8. | Identification and Classification of Members of the Group: |
Item 9. | Notice of Dissolution of a Group: |
Item 10. | Certifications: |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| ||
Dated: February 10, 2022 | ||
XENCOR, INC. | ||
By: | /s/ John J. Kuch | |
John J. Kuch, | ||
Senior Vice President and Chief Financial Officer | ||
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)